Identification of inflammatory biomarkers for pediatric malarial: Anemia severity using novel statistical methods

Infection and Immunity

Volumn 79, Issue 11, 2011, Pages 4674-4680

  Ong'echa, John M ^a   Davenport, Gregory C ^b   Vulule, John M ^c   Hittner, James B ^d   Perkins, Douglas J ^a,b  

^a UNIVERSITY OF NEW MEXICO   (United States)

^b UNIVERSITY OF NEW MEXICO SCHOOL OF MEDICINE   (United States)

^c KENYA MEDICAL RESEARCH INSTITUTE   (Kenya)

^d School of Business   (Kenya)

Author keywords

[No Author keywords available]

Indexed keywords

ALPHA INTERFERON; BIOLOGICAL MARKER; EOTAXIN; GAMMA INTERFERON; GAMMA INTERFERON INDUCIBLE PROTEIN 10; GLUCOSE 6 PHOSPHATE DEHYDROGENASE; GRANULOCYTE MACROPHAGE COLONY STIMULATING FACTOR; HEMOGLOBIN; INTERLEUKIN 1 RECEPTOR BLOCKING AGENT; INTERLEUKIN 10; INTERLEUKIN 12P70; INTERLEUKIN 13; INTERLEUKIN 15; INTERLEUKIN 17; INTERLEUKIN 1BETA; INTERLEUKIN 2; INTERLEUKIN 2 RECEPTOR; INTERLEUKIN 4; INTERLEUKIN 5; INTERLEUKIN 6; INTERLEUKIN 7; INTERLEUKIN 8; MACROPHAGE INFLAMMATORY PROTEIN 1ALPHA; MACROPHAGE INFLAMMATORY PROTEIN 1BETA; MONOCYTE CHEMOTACTIC PROTEIN 1; RANTES; TUMOR NECROSIS FACTOR ALPHA;

ARTICLE; BLOOD ANALYSIS; BLOOD SMEAR; CHILD; CLINICAL EVALUATION; CONTROLLED STUDY; CYTOKINE PRODUCTION; DISEASE SEVERITY; FEMALE; HUMAN; INFLAMMATION; MAJOR CLINICAL STUDY; MALARIA; MALARIA FALCIPARUM; MALE; MIXED INFECTION; PREDICTOR VARIABLE; PRESCHOOL CHILD; PRIORITY JOURNAL; PROTEIN ANALYSIS; SEVERE MALARIAL ANEMIA; SICKLE CELL TRAIT;

ANEMIA; BIOLOGICAL MARKERS; CHILD, PRESCHOOL; CYTOKINES; DATA INTERPRETATION, STATISTICAL; FEMALE; GENE EXPRESSION REGULATION; HEMOGLOBINS; HUMANS; INFANT; INFLAMMATION; KENYA; MALARIA, FALCIPARUM; MALE; RECEPTORS, CYTOKINE;

EID: 80855157093     PISSN: 00199567     EISSN: 10985522     Source Type: Journal    
DOI: 10.1128/IAI.05161-11     Document Type: Article

References (52)

1. Abdalla, S. H. 1988. Peripheral blood and bone marrow leucocytes in Gambian children with malaria: numerical changes and evaluation of phagocytosis. Ann. Trop. Paediatr. 8:250-258.
2. Armah, H. B., et al. 2007. Cerebrospinal fluid and serum biomarkers of cerebral malaria mortality in Ghanaian children. Malar. J. 6:147.
3. Awandare, G. A., et al. 2011. Mechanisms of erythropoiesis inhibition by malarial pigment and malaria-induced proinflammatory mediators in an in vitro model. Am. J. Hematol. 86:155-162.
4. Banovic, T., et al. 2009. Graft-versus-host disease prevents the maturation of plasmacytoid dendritic cells. J. Immunol. 182:912-920.
5. Berkley, J., S. Mwarumba, K. Bramham, B. Lowe, and K. Marsh. 1999. Bacteraemia complicating severe malaria in children. Trans. R. Soc. Trop. Med. Hyg. 93:283-286.
6. Bloland, P. B., et al. 1999. Longitudinal cohort study of the epidemiology of malaria infections in an area of intense malaria transmission. II. Descriptive epidemiology of malaria infection and disease among children. Am. J. Trop. Med. Hyg. 60:641-648.
7. Camacho, L. H., et al. 1998. The course of anaemia after the treatment of acute, falciparum malaria. Ann. Trop. Med. Parasitol. 92:525-537.
8. Camacho, L. H., et al. 1999. The eosinophilic response and haematological recovery after treatment for Plasmodium falciparum malaria. Trop. Med. Int. Health 4:471-475.
9. Cao, Y., et al. 2010. The cytokine/chemokine pattern in the bone marrow environment of multiple myeloma patients. Exp. Hematol. 38:860-867.
10. Chang, K. H., and M. M. Stevenson. 2004. Malarial anaemia: mechanisms and implications of insufficient erythropoiesis during blood-stage malaria. Int. J. Parasitol. 34:1501-1516.
11. Clark, I. A., A. C. Budd, L. M. Alleva, and W. B. Cowden. 2006. Human malarial disease: a consequence of inflammatory cytokine release. Malar. J. 5:85.
12. Efron, B., T. Hastie, I. Johnstone, and R. Tibshirani. 2004. Least angle regression. Ann. Stat. 32:407-499.
13. el-Nashar, T. M., H. M. el-Kholy, A. G. el-Shiety, and A. A. Al-Zahaby. 2002. Correlation of plasma levels of tumor necrosis factor, interleukin-6 and nitric oxide with the severity of human malaria. J. Egypt. Soc. Parasitol. 32:525-535.
14. Findlay, E. G., et al. 2010. Essential role for IL-27 receptor signaling in prevention of Th1-mediated immunopathology during malaria infection. J. Immunol. 185:2482-2492.
15. Hugosson, E., S. M. Montgomery, Z. Premji, M. Troye-Blomberg, and A. Bjorkman. 2004. Higher IL-10 levels are associated with less effective clearance of Plasmodium falciparum parasites. Parasite Immunol. 26:111-117.
16. Jain, V., et al. 2008. Plasma IP-10, apoptotic and angiogenic factors associated with fatal cerebral malaria in India. Malar. J. 7:83.
17. Jakobsen, P. H., et al. 1994. Increased concentrations of interleukin-6 and interleukin-1 receptor antagonist and decreased concentrations of beta-2-glycoprotein I in Gambian children with cerebral malaria. Infect. Immun. 62:4374-4379.
18. Jakobsen, P. H., et al. 1994. Increased plasma levels of soluble IL-2R are associated with severe Plasmodium falciparum malaria. Clin. Exp. Immunol. 96:98-103.
19. John, C. C., R. Opika-Opoka, J. Byarugaba, R. Idro, and M. J. Boivin. 2006. Low levels of RANTES are associated with mortality in children with cerebral malaria. J. Infect. Dis. 194:837-845.
20. John, C. C., G. S. Park, N. Sam-Agudu, R. O. Opoka, and M. J. Boivin. 2008. Elevated serum levels of IL-1ra in children with Plasmodium falciparum malaria are associated with increased severity of disease. Cytokine 41:204-208.
21. Kabyemela, E. R., et al. 2008. Maternal peripheral blood level of IL-10 as a marker for inflammatory placental malaria. Malar. J. 7:26.
22. Keller, C. C., et al. 2006. Acquisition of hemozoin by monocytes downregulates interleukin-12 p40 (IL-12p40) transcripts and circulating IL-12p70 through an IL-10-dependent mechanism: in vivo and in vitro findings in severe malarial anemia. Infect. Immun. 74:5249-5260.
23. Kurtzhals, J. A., et al. 1998. Low plasma concentrations of interleukin 10 in severe malarial anaemia compared with cerebral and uncomplicated malaria. Lancet 351:1768-1772.
24. Kurtzhals, J. A., et al. 1999. The cytokine balance in severe malarial anemia. J. Infect. Dis. 180:1753-1755.
25. Kurtzhals, J. A., et al. 1998. Increased eosinophil activity in acute Plasmodium falciparum infection-association with cerebral malaria. Clin. Exp. Immunol. 112:303-307.
26. Luty, A. J. F., et al. 2000. Low interleukin-12 activity in severe Plasmodium falciparum malaria. Infect. Immun. 68:3909-3915.
27. Lyke, K. E., et al. 2004. Serum levels of the proinflammatory cytokines interleukin-1 beta (IL-1β), IL-6, IL-8, IL-10, tumor necrosis factor alpha, and IL-12(p70) in Malian children with severe Plasmodium falciparum malaria and matched uncomplicated malaria or healthy controls. Infect. Immun. 72:5630-5637.
28. Marsh, K., et al. 1995. Indicators of life-threatening malaria in African children. N. Engl. J. Med. 332:1399-1404.
29. McElroy, P. D., et al. 1999. Analysis of repeated hemoglobin measures in full-term, normal birth weight Kenyan children between birth and four years of age. III. The Asembo Bay Cohort Project. Am. J. Trop. Med. Hyg. 61:932-940.
30. Minty, A., et al. 1993. Interleukin-13 is a new human lymphokine regulating inflammatory and immune responses. Nature 362:248-250.
31. Mohan, K., and M. M. Stevenson. 1998. Dyserythropoiesis and severe anaemia associated with malaria correlate with deficient interleukin-12 production. Br. J. Haematol. 103:942-949.
32. Mohan, K., and M. M. Stevenson. 1998. Interleukin-12 corrects severe anemia during blood-stage Plasmodium chabaudi AS in susceptible A/J mice. Exp. Hematol. 26:45-52.
33. Obonyo, C. O., J. Vulule, W. S. Akhwale, and D. E. Grobbee. 2007. Inhospital morbidity and mortality due to severe malarial anemia in western Kenya. Am. J. Trop. Med. Hyg. 77:23-28.
34. Ochiel, D. O., et al. 2005. Differential regulation of β-chemokines in children with Plasmodium falciparum malaria. Infect. Immun. 73:4190-4197.
35. Okiro, E. A., V. A. Alegana, A. M. Noor, and R. W. Snow. 2010. Changing malaria intervention coverage, transmission and hospitalization in Kenya. Malar. J. 9:285.
36. Ong'echa, J. M., et al. 2006. Parasitemia, anemia, and malarial anemia in infants and young children in a rural holoendemic Plasmodium falciparum transmission area. Am. J. Trop. Med. Hyg. 74:376-385.
37. Ong'echa, J. M., et al. 2003. Association of interferon-gamma responses to pre-erythrocytic stage vaccine candidate antigens of Plasmodium falciparum in young Kenyan children with improved hemoglobin levels. XV. Asembo Bay Cohort Project. Am. J. Trop. Med. Hyg. 68:590-597.
38. Ong'echa, J. M., et al. 2008. Increased circulating interleukin (IL)-23 in children with malarial anemia: in vivo and in vitro relationship with coregulatory cytokines IL-12 and IL-10. Clin. Immunol. 126:211-221.
39. Othoro, C., et al. 1999. A low interleukin-10 tumor necrosis factor-alpha ratio is associated with malaria anemia in children residing in a holoendemic malaria region in western Kenya. J. Infect. Dis. 179:279-282.
40. Otieno, R. O., et al. 2006. Increased severe anemia in HIV-1-exposed and HIV-1-positive infants and children during acute malaria. AIDS 20:275-280.
41. Perkins, D. J., J. B. Weinberg, and P. G. Kremsner. 2000. Reduced interleukin-12 and transforming growth factor-beta1 in severe childhood malaria: relationship of cytokine balance with disease severity. J. Infect. Dis. 182:988-992.
42. Ponath, P. D., et al. 1996. Cloning of the human eosinophil chemoattractant, eotaxin. Expression, receptor binding, and functional properties suggest a mechanism for the selective recruitment of eosinophils. J. Clin. Invest. 97: 604-612.
43. Riccio, E. K., et al. 2003. Malaria associated apoptosis is not significantly correlated with either parasitemia or the number of previous malaria attacks. Parasitol. Res. 90:9-18.
44. Schmid-Grendelmeier, P., et al. 2002. Eosinophils express functional IL-13 in eosinophilic inflammatory diseases. J. Immunol. 169:1021-1027.
45. Stevenson, N. J., et al. 2009. CCL11 blocks IL-4 and GM-CSF signaling in hematopoietic cells and hinders dendritic cell differentiation via suppressor of cytokine signaling expression. J. Leukoc. Biol. 85:289-297.
46. Svatek, R. S., et al. 2009. Pre-treatment biomarker levels improve the accuracy of post-prostatectomy nomogram for prediction of biochemical recurrence. Prostate 69:886-894.
47. Torres, A., et al. 2009. Mathematical modeling of posthemorrhage inflammation in mice: studies using a novel, computer-controlled, closed-loop hemorrhage apparatus. Shock 32:172-178.
48. Vodovotz, Y. 2006. Deciphering the complexity of acute inflammation using mathematical models. Immunol. Res. 36:237-245.
49. Were, T., et al. 2006. Suppression of RANTES in children with Plasmodium falciparum malaria. Haematologica 91:1396-1399.
50. WHO. 2008. World malaria report 2008. World Health Organization, Geneva, Switzerland.
51. Wilson, N. O., et al. 2010. Elevated levels of IL-10 and G-CSF associated with asymptomatic malaria in pregnant women. Infect. Dis. Obstet. Gynecol. doi:10.1155/2010/317430.
52. Wilson, S., et al. 2009. Hepatosplenomegaly associated with chronic malaria exposure: evidence for a pro-inflammatory mechanism exacerbated by schistosomiasis. Parasite Immunol. 31:64-71.